Fears of a link between testosterone replacement therapy and cardiovascular risk are misplaced, according to a review published in this month's Mayo Clinic Proceedings. The therapy has come under widespread scrutiny in recent months, including by a federal Food and Drug Administration panel convened last fall.
from The Medical News http://ift.tt/1BwsX8U
from The Medical News http://ift.tt/1BwsX8U
No comments:
Post a Comment